Understanding the AAPOS Position on Vision Therapy — And Where It Falls Short

Many parents are told that vision therapy “doesn’t work” or is only supported for one narrow diagnosis. The reality is more nuanced. Here is what the AAPOS position actually says, where it is fair, and where it falls short for families trying to understand functional vision problems.

Parents often come to us after hearing some version of the same message: vision therapy doesn’t work, it’s only useful for convergence insufficiency, or it has nothing to do with reading problems. That creates confusion fast. It also puts families in a difficult position, as they try to determine whether their child has a true visual problem, a learning issue, or both. AAPOS’s current public glossary does take a position on vision therapy, and that position is more skeptical than what many developmental optometrists see clinically every day.

To be fair, AAPOS is not wrong about everything. Their glossary correctly distinguishes dyslexia from a primary eye problem and acknowledges that orthoptic eye exercises can help with binocular disorders such as convergence insufficiency. But where the statement falls short is in how broadly it dismisses other functional vision problems and how easily families can walk away thinking that anything beyond a very narrow category is automatically unscientific or illegitimate.

What AAPOS actually says

AAPOS currently defines vision therapy as an attempt to improve visual skills, comfort, eye coordination, and visual processing, usually through monitored in-office and at-home exercises over weeks to months. It also states that lenses, prisms, filters, patches, electronic targets, and balance boards may be used. Then it divides vision therapy into categories and says that “behavioral vision therapy has not been proven by science to work,” while also stating that orthoptic exercises can help certain eye movement problems, such as convergence insufficiency.

That is the core tension. On one hand, the glossary acknowledges that vision therapy can involve a broad range of visual functions and tools. On the other hand, it dismisses the broader functional-developmental side of care in a very sweeping way. For families, that creates a message that is simple, memorable, and often misleading: some eye exercises are real, but the rest are basically not.

1. The problem starts with how the issue is framed

The biggest issue is not that AAPOS wants evidence. It absolutely should. The problem is that the public-facing statement compresses a very wide range of visual skills and treatment goals into a single bucket labeled “behavioral/perceptual vision therapy,” then dismisses that entire bucket in a single sentence. That framing makes it sound as if every non-orthoptic therapy recommendation is the same kind of claim and carries the same level of evidence. That is not how real patients present, and it is not how real treatment planning works.

In practice, patients do not walk in saying, “I would like behavioral vision therapy.” They walk in with problems: double vision, poor convergence, unstable focus, headaches, visual fatigue, skipping lines, losing place, poor tracking, motion sensitivity, reduced visual endurance, weak visual-motor integration, or difficulty sustaining visual attention. Those are not all the same problem, and they should not be treated as if they all hinge on a single generic statement. This is partly an inference, but it follows directly from AAPOS’s own broad definition of vision therapy and from the fact that controlled evidence is strongest for some subtypes of visual dysfunction and weaker for others.

2. The dyslexia point is true — but often misunderstood

This is where families need the most clarity.

Dyslexia is not caused by an eye problem. The joint statement from the American Academy of Pediatrics, the American Academy of Ophthalmology, and AAPOS states that vision problems can interfere with learning but are not the cause of primary dyslexia or learning disabilities. That part is important, and we agree with it.

But that is not the same as saying vision is irrelevant to reading.

Even the ophthalmology side of the debate acknowledges that vision problems can interfere with learning. The optometric position is more specific: vision therapy does not directly treat dyslexia, but it may improve visual efficiency and processing, making the patient more responsive to instruction. That distinction matters. A child can have a language-based reading disorder and a visual efficiency problem. Treating the visual problem does not cure dyslexia, but it may remove one barrier that is making reading harder, more fatiguing, or less sustainable.

That is where the public conversation often goes off track. Families hear, “Vision therapy does not treat dyslexia,” and what they take away is, “Vision has nothing to do with my child’s reading difficulty.” Those are not the same statement. The first can be accurate. The second is too simplistic.

3. The evidence conversation is too narrow

AAPOS is right that the strongest randomized controlled trial evidence is for symptomatic convergence insufficiency. That is a real strength of the literature, not something to minimize. Office-based vergence/accommodative therapy has shown benefit for symptomatic convergence insufficiency, and more recent reviews also support its effectiveness for accommodative dysfunction that coexists with convergence insufficiency.

But from there, many families are led to a broader conclusion that does not logically follow: if the evidence is strongest for convergence insufficiency, then everything else must be junk. That is not how clinical science works. In many areas of rehabilitation, evidence develops unevenly. Some diagnoses get large multicenter trials. Others have smaller studies, retrospective data, physiologic rationale, and years of clinical pattern recognition before the literature catches up. It is appropriate to say that not every application of vision therapy has the same quality of evidence. It is not appropriate to flatten that into a blanket dismissal. The evidence is strongest in some areas, emerging in others, and incomplete in many.

4. Function is not the same thing as pathology

AAPOS’s public materials are written from a pediatric ophthalmology and strabismus perspective. That perspective is naturally centered on disease, amblyopia, ocular alignment, surgical problems, and orthoptics. That is a legitimate lens, but it is not the only lens through which patients experience visual difficulty. AAPOS itself describes its doctors as specialists in children’s eye problems and adult eye alignment, which helps explain why its public guidance is strongest where pathology and alignment-based care are strongest.

Functional vision care asks a different question: not only are the eyes healthy, but also, how efficiently is the visual system performing in real life? A patient can have good acuity and healthy eyes and still struggle with binocular control, visual stamina, focusing flexibility, or sustained near work. That does not make the pathology model wrong. It means the pathology model is not designed to answer every functional question. This is an inference based on the scope of the AAPOS materials and the conditions they publicly emphasize.

5. Families deserve a more precise message

A more accurate public message would sound something like this:

• Vision therapy does not treat dyslexia itself.

• Vision therapy may treat visual dysfunctions that interfere with reading comfort, efficiency, endurance, or performance.

• The evidence base is strongest for some conditions, especially convergence insufficiency.

• Other uses should be discussed honestly in terms of diagnosis, mechanism, goals, and level of evidence.

• No family should be told that a functional visual problem is automatically meaningless just because it does not fit neatly into a surgical or disease-based model.

  
  

That kind of message would be more helpful to parents because it is more clinically honest. It protects families from exaggerated claims, but also from premature dismissal.

What we want parents to understand

If you are a parent trying to sort through all of this, the most important takeaway is this: the question is not whether vision therapy “works” in the abstract. The question is what diagnosis is present, what visual functions are impaired, what the treatment goal is, and what evidence supports that specific recommendation.

That is the right standard.

Not every child who struggles in school needs vision therapy. Not every child with dyslexia has a visual issue. Not every recommendation labeled “vision therapy” is equally evidence-based. But it is also true that some children have measurable visual dysfunctions that are absolutely relevant to comfort, efficiency, and performance, and those deserve to be evaluated on their own terms rather than dismissed with a one-line statement.

Final takeaway

AAPOS is right to push for evidence and right to clarify that dyslexia is not caused by the eyes. Where its public position falls short is in how easily families can come away believing that anything beyond a very narrow orthoptic model is unsupported or not worth considering.

That is too blunt.

The better approach is to separate the three questions clearly:

1. Is there a true visual dysfunction?

2. Is that dysfunction affecting real-life performance?

3. Does the proposed treatment match the diagnosis and the evidence?

That is the conversation families actually need.

Not sure whether your child’s struggles are language-based, vision-based, or both? Start with a developmental vision evaluation to identify what is actually going on and whether vision therapy is the right fit.